Read the numbers before the market does.
Independent UK and US equity research, dated and sourced, with the opinion kept honestly apart from the facts. No hype, no tips, no sponsors — one subscription pays for all of it, and the first month costs nothing.
Premium isn't on sale yet. Until it is, every account has full access, and we'll tell account holders before anything changes.
- The full RNS list, live — not three days late
- A summary of every RNS the moment it lands
- Articles on the news as it comes in, every working day
- Unlimited use of the company data system
- Unlimited articles — free readers get three a month
The news as it lands, with no daily limit
The full RNS list, live
Every regulatory announcement for the covered companies the moment it is published. Free readers see the list only once an announcement is three days old.
RNS summaries, immediately
Each announcement comes with a plain-English summary of what it says and why it matters, published at the same time as the RNS itself, every working day.
Articles on the day's news
As news comes in on a working day, the article follows: what happened, what it means for the companies covered and whether the verdict changes. Free readers can read them within their three articles a month.
The company data system, unlimited
Unlimited use of the company data system: the figures behind every assessment, company by company. Free readers get 3 uses a day.
Unlimited reading
Free readers get three articles a calendar month. Premium removes the limit across the company assessments, the Trading Log, the Long Reads and The Greats.
Save 15% on the annual plan
After your free month, pay £101.90 for twelve months instead of £9.99 a month: the equivalent of £8.49 a month, billed once a year.
How it works
Equity and Markets Insight is written by one private investor, Mickey Perry, who trades his own money and publishes the research he does for himself. There are no sponsors, no paid promotion and no broker relationships. Where I hold a position in a company I say so.
This is research and opinion, not investment advice. Investing involves risk, including loss of capital.
Questions
How does the free month work?
You get the whole of Premium for 30 days without paying: the live RNS list and summaries, the daily articles, unlimited reading and the company data system. Card details are taken at the start and nothing is charged until the free month ends. Cancel before then and you pay nothing; stay, and it is £9.99 a month, or £101.90 a year, from day 31.
Can I cancel whenever I want?
Yes. During the free month, cancelling costs nothing. After that, cancel from your account page and you keep Premium until the end of the period you have paid for. No calls, no forms.
What stays free?
Today's Weather, the Verdict Board, the quizzes, the infographics, the Guidance Tracker and the Financial Calendar. Articles are free up to three a calendar month, RNS news once an announcement is three days old, and the company data system up to 3 uses a day. See the comparison →
Is there an annual plan?
Yes. After the free month, £101.90 for twelve months, which is 15% off the monthly price — the equivalent of £8.49 a month. It is billed once a year and you can cancel before the renewal date.
Is this investment advice?
No. It is independent research and my own opinion, written for people who want to do their own work. I am not a financial adviser and nothing here is a recommendation to buy or sell.
How often is new research published?
Every working day. Articles follow the news as it comes in, and each RNS gets its summary the moment the announcement lands. Full company assessments are published as the work on each one is finished.